Dr Eva Hofstädter-Thalmann
Janssen The Pharmaceutical Companies of J&J, Austria
Eva Thalmann is External Scientific Relations Lead for Oncology at Janssen Medical Affairs Europe, Middle East and Africa. Throughout Eva’s career she has worked in Haematology/Oncology, Immunology, Nephrology and Virology. Her focus is on strong strategic collaborations to major oncology societies, top experts and publishers. Her other focus is on strategic quality aspects for Janssen in education over all disease areas. Eva is member of several external strategic groups, including International Pharmaceutical Alliance for Medical Education (iPACME) Lead, the Board of Directors for Global Alliance for Medical Education (GAME), Board Member of the Journal of European CME (JECME), Chair of the European Federation of Pharmaceutical Industries and Associations (EFPIA) Medical Education Working Group, and Co-chair of the European Society for Medical Oncology (ESMO)/Industry Working Group. Eva obtained her PhD in Biochemistry from the University of Vienna, Austria. She had various positions in Medical Affairs and Strategic Marketing for Janssen-Cilag and Johnson & Johnson within both Europe and the US.